An Inpatient Advance Care Planning Intervention for Older Patients With Hematologic Malignancies
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 41
- 试验地点
- 1
- 主要终点
- Retention Rate
研究概览
简要总结
This is a pilot study to assess the preliminary efficacy of an inpatient advance care planning intervention on outcomes in older patients with hematologic malignancies
详细描述
Older adults with hematologic malignancies receive more aggressive inpatient care at the end of life compared to patients with solid tumors. Advance care planning may promote early serious illness conversations for patients with hematologic malignancies, leading to less aggressive healthcare utilization at the end of life. This pilot aims to assess the preliminary efficacy of an inpatient advance care planning intervention on outcomes in older patients with hematologic malignancies.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 60 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age ≥60 years
- •A diagnosis of hematologic malignancy [including but not limited to acute leukemia, myeloid malignancies (e.g., atypical CML, MDS/MPN overlap syndromes, CMML), multiple myeloma, lymphoma, or any other hematologic malignancies based on the primary oncologist's judgment]
- •Able to provide informed consent
- •Being managed in the inpatient setting
- •English-speaking
排除标准
- 未提供
研究组 & 干预措施
Experimental
Patients will participate in an inpatient advance care planning intervention.
干预措施: Inpatient serious illness care program (Behavioral)
结局指标
主要结局
Retention Rate
时间窗: From consent until completion of the ACP intervention visit, usually within 1 week.
Retention rate is the percentage of consented patients who completed the ACP intervention visit. A retention rate of \>70% was considered feasible.
次要结局
- Advance Directive Completion - HCP(From baseline (pre-intervention) to 1 year post-intervention. The time interval is approximately 1 year.)
- Advance Directive Completion - MOLST(From baseline (pre-intervention) to 1 year post-intervention. The time interval is approximately 1 year.)
研究者
Kah Poh Loh
Associate Professor - Department of Medicine, Hematology/Oncology (SMD)
University of Rochester